BFL-1 -1182*G/C PROMOTER POLYMORPHISM INFLUENCES PRIMARY RESPONSE RATE TO INFLIXIMAB IN PATIENTS WITH ULCERATIVE COLITIS

(1) University Medical, Centre Ljubljana, Dept. of Gastroenterology, Ljubljana, Slovenia

(2) Department of Gastroenterology, UNIVERSITY HOSPITALGASTHUISBERG, LEUVEN, Belgium



This item was part of the Inflammatory Bowel Disease III session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A403

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2010